TBPN

$2B Allergy Drug, ChatGPT Ads, Mansion Section | Billy Boman, Benjamin Miller, Faris Sbahi, Evan Loomis, Anvisha Pai, Ryan Tseng

40 snips
Mar 27, 2026
Billy Boman, AI visual creator and educator, talks AI commercials, music videos, and why taste beats prompt tricks. Benjamin Miller, Fundrise co-founder, gets into publicly tradable private tech investing. Anvisha Pai, Moda founder, explores editable AI design tools. Ryan Tseng, Shield AI co-founder, covers autonomous aircraft and simulation. Plus: a $2B allergy drug deal, ChatGPT ads, and mansion mania.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Liquidity Itself Can Be The Product In Private Markets

  • A liquid public wrapper around elite private companies can command a premium because ordinary investors cannot otherwise buy those shares at par.
  • Benjamin Miller said VCX offers Anthropic, Anduril, OpenAI, Ramp, and Databricks exposure with liquidity and no carried interest.
INSIGHT

Thermodynamic Chips Add Noise As A New Optimization Axis

  • The next chip frontier is not just speed or power efficiency but noise-tolerant hardware matched to probabilistic AI workloads.
  • Faris Sbahi said thermodynamic computing fits diffusion-style models where approximation is native, unlike deterministic calculator-style tasks.
INSIGHT

The Next National Advantage Will Be Built In Deep Tech

  • Overmatch is investing in deep tech, defense, and space because the next strategic era will be defined by AI, chips, autonomy, and hypersonics.
  • Evan Loomis said America feels behind in some areas but still wins when founders are allowed to build impossible things.
Get the Snipd Podcast app to discover more snips from this episode
Get the app